Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Dr Anna Moltó is an attending rheumatologist in the Rheumatology Department of Cochin Hospital, Paris, France, and also acts as a clinical researcher in the INSERM ECAMO team (U-1153) from the University of Paris, France.
She completed both her medical studies and rheumatology training at Universitat Autónoma de Barcelona, Spain, in 2010. She completed a clinical research fellowship in Paris, and in 2011, was an assistant professor at Cochin Hospital. Dr Moltó was co-opted by Emerging EULAR Network (EMEUNET) in 2010, where she first served as part of the Country Liaisons subgroup, subsequently as its leader. She was elected Chair of EMEUNET in 2015.
Dr Moltó’s research focuses mainly on the natural history of early axial spondyloarthritis, evaluation of effectiveness in observational trials and pregnancy outcomes in patients with inflammatory rheumatic diseases. She has authored more than 100 peer-reviewed publications.
Explore factors impacting RA and axSpA management, such as radiographic progression, and sex and gender differences.
Integrating holistic care through guideline recommendations with patient-reported outcomes and shared decision-making
Personalised HS care: Addressing the multi-faceted burden of HS with a case study example
The role of combined medical/surgical and medical-only treatments, including the optimal time for intervention
Key guideline updates including management algorithms for inflammatory and non-inflammatory HS phenotypes
Prof. Prignano and Prof. Liakou discuss patient-reported outcomes, shared decision-making and multidisciplinary HS care